Literature DB >> 23981574

Chronic inflammation and gallbladder cancer.

Yumin Li1, Junqiang Zhang2, Haizhen Ma3.   

Abstract

Gallbladder cancer (GBC) is the most common biliary tract malignancy with an extremely poor prognosis. Epidemiological data have demonstrated that chronic inflammation resulting from infection of gallbladder or gallstones predispose individuals to GBC. Recent studies have begun to elucidate molecular mechanisms underlying the development of GBC in the setting of chronic inflammation. It is possible that persistently local inflammatory reactions may contribute to the development and progression of GBC through inducing genetic alterations, and subsequent promoting survival and proliferation of mutated sells, inhibiting apoptosis, stimulating angiogenesis and metastasis. This article reviews the current understanding of the involvement of chronic inflammation in gallbladder tumorigenesis.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Aetiology; Chronic inflammation; Gallbladder cancer; Pathogenesis

Mesh:

Substances:

Year:  2013        PMID: 23981574     DOI: 10.1016/j.canlet.2013.08.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  The role of H. pylori infection in gall bladder cancer: clinicopathological study.

Authors:  Ehsan Hassan Hassan; Shawkat S Gerges; Kamal A El-Atrebi; Hala T El-Bassyouni
Journal:  Tumour Biol       Date:  2015-04-16

2.  Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma.

Authors:  Lingqiang Zhang; Ruitao Wang; Wei Chen; Xinsen Xu; Shunbing Dong; Haining Fan; Chang Liu
Journal:  HPB (Oxford)       Date:  2016-05-06       Impact factor: 3.647

3.  Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.

Authors:  Jing-Hui Du; Jun Lu
Journal:  J Clin Lab Anal       Date:  2018-11-21       Impact factor: 2.352

4.  Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma.

Authors:  Qing Pang; Ling-Qiang Zhang; Rui-Tao Wang; Jian-Bin Bi; Jing-Yao Zhang; Kai Qu; Su-Shun Liu; Si-Dong Song; Xin-Sen Xu; Zhi-Xin Wang; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

5.  Cadmium exposure activates Akt/ERK Signaling and pro-inflammatory COX-2 expression in human gallbladder epithelial cells via a ROS dependent mechanism.

Authors:  Priyanka Sharma; Trevar S Caldwell; Megan N Rivera; Rama R Gullapalli
Journal:  Toxicol In Vitro       Date:  2020-06-06       Impact factor: 3.500

6.  Up-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs.

Authors:  Feiyan Ai; Xuemei Zhang; Xiayu Li; Zailong Qin; Qiurong Ye; Li Tian; Anliu Tang; Nan Li; Guiyuan Li; Jian Ma; Shourong Shen
Journal:  Oncotarget       Date:  2015-03-10

7.  Anti-inflammatory properties of the medicinal mushroom Cordyceps militaris might be related to its linear (1→3)-β-D-glucan.

Authors:  Fhernanda R Smiderle; Cristiane H Baggio; Débora G Borato; Arquimedes P Santana-Filho; Guilherme L Sassaki; Marcello Iacomini; Leo J L D Van Griensven
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

8.  TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway.

Authors:  HaiJie Hong; Lei Jiang; YanFei Lin; CaiLong He; GuangWei Zhu; Qiang Du; XiaoQian Wang; FeiFei She; YanLing Chen
Journal:  BMC Cancer       Date:  2016-03-19       Impact factor: 4.430

9.  Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer.

Authors:  Zhiwei Liu; Troy J Kemp; Yu-Tang Gao; Amanda Corbel; Emma E McGee; Juan Carlos Roa; Bingsheng Wang; Juan Carlos Araya; Ming-Chang Shen; Asif Rashid; Ann W Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M Pfeiffer; Ligia A Pinto; Jill Koshiol
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

Review 10.  MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers.

Authors:  Yixin Yang; Christopher Alderman; Ayoub Sehlaoui; Yuan Xiao; Wei Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.